June 23,2005

Senate Finance Committee to Examine Medicaid Fraud, Waste and Abuse

WASHINGTON — The Senate Committee on Finance will hold two days of hearings next week to consider how fraud, waste and abuse harm the Medicaid program.

The first hearing is scheduled for Tuesday, June 28, at 10 a.m. in Room 216 of the HartSenate Office Building. The committee will consider differences between Medicaid andMedicare oversight and how the complexity of the Medicaid program makes it difficult tooversee and account for misuse. The committee will also review various ways the states accessfederal Medicaid dollars.

The following witnesses are scheduled to testify on Tuesday.

Panel 1 —

Mr. Daniel Levinson, Inspector General
Office of the Inspector General, U.S. Department of Health and Human Services
Washington, DC

Ms. Leslie Aronovitz, Director, Health Care
Government Accountability Office
Chicago, Illinois

Mr. James W. Moorman, President and CEO
Taxpayers Against Fraud
Washington, DC

Mr. Nicholas Messuri, President, National Association of Medicaid Fraud Control Units
Assistant Attorney General, Director Medicaid Fraud Control Unit
Bureau Chief, Business & Labor Protection Bureau
Massachusetts Office of the Attorney General
Boston, Massachusetts

Mr. Tim Westmoreland, Research Professor
Georgetown University
Washington, DC

Panel 2 —

Ms. Kathryn Allen, Director, Health Care
Government Accountability Office
Washington, DC

Mr. Dennis Smith, Director, Center for Medicaid and State Operations
Center for Medicare and Medicaid Services, U.S. Department of Health and Human Services
Washington, DC

Ms. Barbara Edwards, Medicaid Director
Office of Ohio Health Plans
Columbus, Ohio

Mr. George Reeb, Assistant Inspector General for the Centers for Medicare & Medicaid Audits
Office of the Inspector General, U.S. Department of Health and Human Services
Washington, DC

Mr. Chuck Milligan, Executive Director
Center for Health Program Development and Management
University of Maryland, Baltimore County
Baltimore, Maryland

The second hearing is scheduled for Wednesday, June 29, at 10 a.m. in room 216 of theHart Senate Office Building. The committee will review Medicaid’s pricing and paymentpolicies for prescription drugs and the practice of transferring assets by older individuals relyingon Medicaid for long-term care needs.

The following witnesses are scheduled to testify on Wednesday.

Panel 1 —

a pharmaceutical industry whistleblower

Mr. Timothy Coleman, Associate Deputy Attorney General
U.S. Department of Justice
Washington, DC

Mr. Robert Vito, Regional Inspector General for Evaluations and Inspections
Office of the Inspector General, U.S. Department of Health and Human Services
Philadelphia, Pennsylvania

Mr. Patrick O’Connell, Assistant Attorney General
Office of the Attorney General, State of Texas
Austin, Texas

Mr. Billy Tauzin, CEO (Invited)
Pharmaceutical Research Manufacturers of America
Washington, DC

Panel 2 —

Mr. Daniel O’Brien, Senior Vice President
Erickson Retirement Communities
Baltimore, Maryland

Ms. Ruth Pundt, Resident
Erickson Retirement Communities
Parkville, Maryland

Ms. Julie Stone, Specialist in Social Legislation
Congressional Research Service
Washington, DC

Mr. Paul Pickerell, Manager, Financial Recoveries Division
Oregon Department of Human Services
Eugene, Oregon

Ms. Joyce Ruddock, Vice President, Long Term Care Division
MetLife Insurance on behalf of American Council of Life Insurers
Westport, Connecticut

Dr. Judy Feder, Dean, Public Policy Institute
Georgetown University
Washington, DC.

-30-